
TIP751: Mastermind Q3, 2025: Uber, Merck, and Bath & Body Works
We Study Billionaires - The Investor’s Podcast Network
00:00
Merck's Oncology Landscape and Future Challenges
This chapter explores Merck's stronghold in the oncology market with its blockbuster drug Keytruda while addressing looming patent expiration and the impact of competitive biosimilars. It also highlights financial challenges regarding drug pricing, inefficiencies caused by middlemen, and Merck’s strategic adaptations in drug delivery methods. The discussion emphasizes the balancing act between current market valuations, investment risk, and future growth potential within the pharmaceutical sector.
Transcript
Play full episode